Cargando…
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
Ligation of the inhibitory receptor NKG2A by its ligand HLA-E negatively regulates the activation of natural killer (NK) cells, as well as subsets of CD8+ T cells and innate T cell populations. NKG2A has recently become a novel immune checkpoint target for the treatment of cancer and direct antibody...
Autores principales: | Fisher, Jack G., Doyle, Amber D. P., Graham, Lara V., Khakoo, Salim I., Blunt, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783329/ https://www.ncbi.nlm.nih.gov/pubmed/36560403 http://dx.doi.org/10.3390/vaccines10121993 |
Ejemplares similares
-
Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
por: Fisher, Jack G., et al.
Publicado: (2021) -
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression
por: Fisher, Jack G., et al.
Publicado: (2023) -
Disruption of the HLA-E/NKG2X axis is associated with uncontrolled HIV infections
por: Romero-Martín, Luis, et al.
Publicado: (2022) -
S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
por: Encinas, Jessica, et al.
Publicado: (2023) -
The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma
por: Warricker, Frazer, et al.
Publicado: (2021)